Exendin-4 Ameliorates Traumatic Brain Injury-Induced Cognitive Impairment in Rats

Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action

(2013) Jonathan E. Campbell et al.   Cell Metabolism

Changes in mouse cognition and hippocampal gene expression observed in a mild physical- and blast-traumatic brain injury

(2013) David Tweedie et al.   NEUROBIOLOGY OF DISEASE

Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders

(2012) Isidro Salcedo et al.   BRITISH JOURNAL OF PHARMACOLOGY

Excitotoxicity: Bridge to various triggers in neurodegenerative disorders

(2012) Ankita Mehta et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Exendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in mice

(2012) David Tweedie et al.   EXPERIMENTAL NEUROLOGY

The Effect of Injury Severity on Behavior: A Phenotypic Study of Cognitive and Emotional Deficits after Mild, Moderate, and Severe Controlled Cortical Impact Injury in Mice

(2012) Patricia M. Washington et al.   JOURNAL OF NEUROTRAUMA

Exendin-4 Ameliorates Motor Neuron Degeneration in Cellular and Animal Models of Amyotrophic Lateral Sclerosis

(2012) Yazhou Li et al.   PLoS One

Neuroprotective properties of GLP-1: theoretical and practical applications

(2011) Jens Juul Holst et al.   CURRENT MEDICAL RESEARCH AND OPINION

Glucagon-like Peptide–1 Analogues for Type 2 Diabetes Mellitus

(2011) Baptist Gallwitz   DRUGS

Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes

(2011) Ann Mosegaard Bak et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Oxidative Stress in Ischemic Brain Damage: Mechanisms of Cell Death and Potential Molecular Targets for Neuroprotection

(2010) Hai Chen et al.   ANTIOXIDANTS & REDOX SIGNALING

Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?

(2010) Niklas Marklund et al.   BRITISH JOURNAL OF PHARMACOLOGY

Differentiating effects of the glucagon-like peptide-1 analogue exendin-4 in a human neuronal cell model

(2010) Paola Luciani et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Diffuse Brain Injury Elevates Tonic Glutamate Levels and Potassium-Evoked Glutamate Release in Discrete Brain Regions at Two Days Post-Injury: An Enzyme-Based Microelectrode Array Study

(2010) Jason M. Hinzman et al.   JOURNAL OF NEUROTRAUMA

Effects of Traumatic Brain Injury of Different Severities on Emotional, Cognitive, and Oxidative Stress-Related Parameters in Mice

(2010) Marcelo L. Schwarzbold et al.   JOURNAL OF NEUROTRAUMA

Chronic treatment of exendin-4 affects cell proliferation and neuroblast differentiation in the adult mouse hippocampal dentate gyrus

(2010) Hua Li et al.   NEUROSCIENCE LETTERS

Long-term Psychiatric Outcomes Following Traumatic Brain Injury

(2009) Dale C. Hesdorffer et al.   JOURNAL OF HEAD TRAUMA REHABILITATION

Incretin-based therapies for type 2 diabetes mellitus

(2009) Julie A. Lovshin et al.   Nature Reviews Endocrinology

Cerebral transplantation of encapsulated mesenchymal stem cells improves cellular pathology after experimental traumatic brain injury

(2009) Anna M.B. Heile et al.   NEUROSCIENCE LETTERS

GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism

(2009) Y. Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Exendin-4 Improves Glycemic Control, Ameliorates Brain and Pancreatic Pathologies, and Extends Survival in a Mouse Model of Huntington's Disease

(2008) B. Martin et al.   DIABETES

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

(2008) Daniel J Drucker et al.   LANCET